A Genomic Approach to Improved Diagnosis and Treatment of Neuroendocrine Tumors

RABL6A inhibits tumor-suppressive PP2A/AKT signaling to drive pancreatic neuroendocrine tumor growth

Shaikamjad Umesalma, Courtney A Kaemmer, Jordan L Kohlmeyer, et al.. (2019). Journal of Clinical Investigation. Cited 30 times. https://doi.org/10.1172/JCI123049

Changes in gene expression in small bowel neuroendocrine tumors associated with progression to metastases

Kendall J. Keck, P. Breheny, T. Braun, et al.. (2018). Surgery. Cited 17 times. https://doi.org/10.1016/j.surg.2017.07.031